MetaCure (USA), Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TANTALUS Therapy in Type 2 Diabetic Patients Intolerant or Inadequately Responsive to GLP-1 Receptor Agonist Therapy (NCT01303315) | MetaCure (USA), Inc. | 2011-01-01 |
| The TANTALUS® II for the Treatment of Type 2 Diabetes (NCT01303302) | MetaCure (USA), Inc. | 2008-04-01 |
| The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study (NCT00547482) | MetaCure (USA), Inc. | 2007-09-01 |
| A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese Patients (NCT00779363) | MetaCure (USA), Inc. | 2004-06-01 |
Track MetaCure (USA), Inc. automatically
Every clearance here is in the API, with alerts when new ones post.